{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:23:30Z","timestamp":1795051410640,"version":"4.10.2"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:p>Antiretroviral therapy, also known as antiretroviral therapy (ART), has been at the forefront of the ongoing battle against human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDs). ART is effective, but it has drawbacks such as side effects, medication resistance, and difficulty getting access to treatment, which highlights the urgent need for novel treatment approaches. This review explores the complex field of HIV\/AIDS treatment, covering both established alternative treatment modalities and orthodox antiretroviral therapy. Numerous reliable databases were reviewed, including PubMed, Web of Science, Scopus, and Google Scholar. The results of a thorough literature search revealed numerous therapeutic options, including stem cell transplantation, immunotherapy, gene therapy, latency reversal agents, and pharmaceutical vaccinations. While gene therapy has promise for altering cellular resistance to infection and targeting HIV-positive cells, immunotherapy treatments seek to strengthen the immune system\u2019s ability to combat HIV. Latency reversal agents offer a promising method of breaking the viral latency and making infected cells vulnerable to immune system destruction or antiretroviral drugs. Furthermore, there is potential for improving immune responses against HIV using medical vaccinations. This review stresses the vital significance of ongoing research and innovation in the hunt for a successful HIV\/AIDS treatment through a thorough examination of recent developments and lingering challenges. The assessment notes that even though there has been tremendous progress in treating the illness, there is still more work to be done in addressing current barriers and investigating various treatment options in order to achieve the ultimate objective of putting an end to the HIV\/AIDS pandemic.<\/jats:p>","DOI":"10.1097\/md.0000000000038768","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T16:04:44Z","timestamp":1720195484000},"page":"e38768","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":40,"title":["Toward a cure \u2013 Advancing HIV\/AIDs treatment modalities beyond antiretroviral therapy: A Review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4105-8615","authenticated-orcid":false,"given":"Esther Ugo","family":"Alum","sequence":"first","affiliation":[{"name":"Department of Research and Publications, Kampala International University, Kampala, Uganda."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Ejim","family":"Uti","sequence":"additional","affiliation":[{"name":"Department of Research and Publications, Kampala International University, Kampala, Uganda."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu Paul-Chima","family":"Ugwu","sequence":"additional","affiliation":[{"name":"Department of Research and Publications, Kampala International University, Kampala, Uganda."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict Nnachi","family":"Alum","sequence":"additional","affiliation":[{"name":"Department of Research and Publications, Kampala International University, Kampala, Uganda."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260109","first-page":"13","article-title":"Factors associated with prevalence of HIV among youths: a review of Africa perspective.","volume":"3","author":"Obeagu","year":"2023","journal-title":"Madonna Univ J Med Health Sci"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"e35673","DOI":"10.1097\/MD.0000000000035673","article-title":"Inclusion of nutritional counseling and mental health services in HIV\/AIDS management: a paradigm shift.","volume":"102","author":"Alum","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R3-20260109","article-title":"Curtailing HIV\/AIDS spread: Impact of Religious Leaders."},{"key":"R4-20260109","article-title":"Neutrophil-derived Inflammation and Pregnancy Outcomes."},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/microorganisms11041050","article-title":"Antimicrobial resistance in the global health network: known unknowns and challenges for efficient responses in the 21st century.","volume":"11","author":"Coque","year":"2023","journal-title":"Microorganisms"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/v15030789","article-title":"Opportunities for CAR-T cell immunotherapy in HIV cure.","volume":"15","author":"Campos-Gonzalez","year":"2023","journal-title":"Viruses"},{"key":"R7-20260109","first-page":"1","article-title":"Reducing HIV infection rate in women: a catalyst to reducing HIV infection pervasiveness in Africa.","volume":"11","author":"Alum","year":"2023","journal-title":"Int J Innov Appl Res"},{"key":"R8-20260109","article-title":"Ways HIV can be transmitted \u2013 HIV transmission \u2013 HIV basics \u2013 HIV\/AIDS \u2013 CDC."},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2022.9925","article-title":"From positive to negative to positive again \u2013 the mystery of why COVID-19 rebounds in some patients who take paxlovid.","volume":"327","journal-title":"JAMA"},{"key":"R10-20260109","first-page":"95","article-title":"HIV infection and cardiovascular diseases.","volume":"3","journal-title":"Eur Heart J"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"43","DOI":"10.59298\/NIJSES\/2023\/10.6.1000","article-title":"Adverse drug reactions in HIV\/AIDS patients on highly active antiretro viral therapy: a review of prevalence.","volume":"4","author":"Obeagu","year":"2023","journal-title":"NIJSES"},{"key":"R13-20260109","first-page":"59","article-title":"Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.","volume":"16","journal-title":"Reproduct Health"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","article-title":"Advancing global health and strengthening the HIV response in the era of the sustainable development goals: the International AIDS Society \u2013 Lancet Commission.","volume":"392","author":"Bekker","year":"2018","journal-title":"Lancet"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/v15081732","article-title":"Current ARTs, virologic failure, and implications for AIDS management: a systematic review.","volume":"15","author":"Foka","year":"2023","journal-title":"Viruses"},{"key":"R16-20260109","article-title":"Combatting stigma: essential steps in halting HIV spread."},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"100017","DOI":"10.1016\/j.jve.2020.100017","article-title":"Re-examining the HIV \u201cfunctional cure\u201d oxymoron: time for precise terminology?","volume":"6","author":"Dub\u00e9","year":"2020","journal-title":"J Virus Erad"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/vaccines9091001","article-title":"Preventive HIV vaccines-leveraging on lessons from the past to pave the way forward.","volume":"9","author":"Sobia","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coviro.2019.07.001","article-title":"Elimination of infectious HIV DNA by CRISPR\u2013Cas9.","volume":"38","author":"Das","year":"2019","journal-title":"Curr Opin Virol"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1007\/s11033-022-07525-8","article-title":"Immunotherapy: an alternative promising therapeutic approach against cancers.","volume":"49","author":"Gupta","year":"2022","journal-title":"Mol Biol Rep"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-med-052716-031710","article-title":"Novel latency reversing agents for HIV-1 cure.","volume":"69","author":"Spivak","year":"2018","journal-title":"Annu Rev Med"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"100082","DOI":"10.1016\/j.jve.2022.100082","article-title":"Combination strategies to durably suppress HIV-1: soluble T cell receptors.","volume":"8","author":"Wallace","year":"2022","journal-title":"J Virus Erad"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/JLB.5VMR0122-046RRR","article-title":"Shock and kill within the CNS: a promising HIV eradication approach?","volume":"112","author":"N\u00fchn","year":"2022","journal-title":"J Leukoc Biol"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3389\/fimmu.2019.02060","article-title":"Immunotherapy in people with HIV and cancer.","volume":"10","author":"Puronen","year":"2019","journal-title":"Front Immunol"},{"key":"R25-20260109","article-title":"INOSR."},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2515135518800689","article-title":"Broadly neutralizing antibodies in HIV-1 treatment and prevention.","volume":"6","author":"Kumar","year":"2018","journal-title":"Ther Adv Vaccines Immunother"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3390\/cells10092227","article-title":"Immune checkpoint inhibitors in people living with HIV\/AIDS: facts and controversies.","volume":"10","author":"Castelli","year":"2021","journal-title":"Cells"},{"key":"R28-20260109","doi-asserted-by":"crossref","first-page":"e20220046","DOI":"10.1590\/1678-4685-gmb-2022-0046","article-title":"Protection is not always a good thing: the immune system\u2019s impact on gene therapy.","volume":"45","author":"de Freitas","year":"2022","journal-title":"Genet Mol Biol"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/21645515.2015.1009809","article-title":"Transient IL-10 receptor blockade can enhance CD8+ T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen.","volume":"11","author":"Clutton","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcimb.2019.00069","article-title":"Application of CRISPR\/Cas9-based gene editing in HIV-1\/AIDS therapy.","volume":"9","author":"Xiao","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"R31-20260109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/pathogens11080891","article-title":"Application of CRISPR-Cas9 gene editing for HIV host factor discovery and validation.","volume":"11","author":"Cisneros","year":"2022","journal-title":"Pathogens"},{"key":"R32-20260109","article-title":"The reservoir of latent HIV-PMC."},{"key":"R33-20260109","doi-asserted-by":"crossref","first-page":"880030","DOI":"10.3389\/fcimb.2022.880030","article-title":"Application of CRISPR\/Cas genomic editing tools for HIV therapy: toward precise modifications and multilevel protection.","volume":"12","author":"Maslennikova","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R35-20260109","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood-2016-01-678144","article-title":"The clinical applications of genome editing in HIV.","volume":"127","author":"Wang","year":"2016","journal-title":"Blood"},{"key":"R36-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virs.2022.01.017","article-title":"Updates on CRISPR-based gene editing in HIV-1\/AIDS therapy.","volume":"37","author":"Zhang","year":"2022","journal-title":"Virol Sin"},{"key":"R37-20260109","article-title":"Editing out HIV: application of gene editing technology to achieve functional cure.","journal-title":"Retrovirology"},{"key":"R38-20260109","first-page":"e17507","article-title":"Stem cell therapy and its significance in HIV infection.","volume":"13","author":"Khalid","year":"2021","journal-title":"Cureus"},{"key":"R39-20260109","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects \u2013 PMC."},{"key":"R40-20260109","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/mt.2015.19","article-title":"Lentivirus-mediated gene transfer in hematopoietic stem cells is impaired in SHIV-infected, ART-treated nonhuman primates.","volume":"23","author":"Younan","year":"2015","journal-title":"Mol Ther"},{"key":"R41-20260109","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy.","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther"},{"key":"R42-20260109","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-019-03156-8","article-title":"Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs.","volume":"76","author":"Sadowski","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"R43-20260109","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jmp.12613","article-title":"The role of latency reversal in HIV cure strategies.","volume":"51","author":"Tanaka","year":"2022","journal-title":"J Med Primatol"},{"key":"R44-20260109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/molecules28010003","article-title":"Medicinal chemistry of Anti-HIV-1 latency chemotherapeutics: biotargets, binding modes and structure-activity relationship investigation.","volume":"28","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"R45-20260109","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S2352-3018(18)30039-0","article-title":"Barriers and strategies to achieve a cure for HIV.","volume":"5","author":"Pitman","year":"2018","journal-title":"Lancet HIV"},{"key":"R46-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.03060","article-title":"Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs.","volume":"10","author":"Ait-Ammar","year":"2020","journal-title":"Front Microbiol"},{"key":"R47-20260109","doi-asserted-by":"crossref","first-page":"590780","DOI":"10.3389\/fimmu.2020.590780","article-title":"Major scientific hurdles in HIV vaccine development: historical perspective and future directions.","volume":"11","author":"Ng\u2019uni","year":"2020","journal-title":"Front Immunol"},{"key":"R48-20260109","doi-asserted-by":"crossref","first-page":"101412","DOI":"10.1016\/j.smim.2020.101412","article-title":"Immunological approaches to HIV cure.","volume":"51","author":"Ward","year":"2021","journal-title":"Semin Immunol"},{"key":"R49-20260109","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40011-021-01237-y","article-title":"HIV\/AIDS: current updates on the disease, treatment and prevention.","volume":"91","author":"Gupta","year":"2021","journal-title":"Proc Natl Acad Sci India Sect B Biol Sci"},{"key":"R50-20260109","first-page":"89","article-title":"Promising stem cell therapy in the management of HIV and AIDS: a narrative review.","volume":"16","author":"Kandula","year":"2022","journal-title":"Biologics"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:05:05Z","timestamp":1767967505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":48,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038768","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}